Human immunodeficiency virus among trauma patients in New York City.
To determine the HIV seroprevalence rates in relation to the demographic characteristics of victims, cause of death, and toxicology findings in a sample of victims of violence and accidents who presented to emergency departments before death.
This descriptive survey of a complete 3-year sample of homicides and accidents was conducted in 5 boroughs of New York City (population 7,322,564).
Persons 15 years of age and older injured by intentional violence or accidents (excluding drug overdoses, falls from short heights, and suicides) who presented to hospitals, died, and were sent to the medical examiner were included.
Standard methods were used to test plasma and serum samples for HIV and cocaine or its metabolite.
X2 Tests compared HIV seroprevalence across groups according to demographic characteristics and toxicology findings.
Logistic regression analysis was done for those variables found to be significant with X2 tests.
All statistical tests were conducted with 2-tailed alpha levels of. 05.
Among the 1,242 subjects in the sample, 90 (7.2%) had positive findings.
Male patients (8%) had higher rates than female patients (3.4%). HIV rates were highest among patients 35 to 44 years of age (20.8%), followed by the 45-to 54-year age group (9.6%) and 25-to 34-year age group (8.1%). Victims of homicide (8.2%) and accidents other than motor vehicle crashes (10.5%) had higher rates than victims of motor vehicle crashes (4%). (...)
Mots-clés Pascal : SIDA, Virose, Infection, Séropositivité, Virus immunodéficience humaine, Lentivirus, Retroviridae, Virus, Traumatisme, Accident corporel, Violence, Unité soin intensif, Epidémiologie, Prévalence, Homme, New York, Etats Unis, Amérique du Nord, Amérique, Immunopathologie, Immunodéficit
Mots-clés Pascal anglais : AIDS, Viral disease, Infection, Seropositivity, Human immunodeficiency virus, Lentivirus, Retroviridae, Virus, Trauma, Personal injury, Violence, Intensive care unit, Epidemiology, Prevalence, Human, New York, United States, North America, America, Immunopathology, Immune deficiency
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0383036
Code Inist : 002B06D01. Création : 25/01/1999.